CuraLinc Appoints Derek Newell as CEO, Ushering in New Era

Portfolio - People | Feb 11, 2025 | Lightyear Capital

CuraLinc Healthcare, a prominent player in workforce mental health and Employee Assistance Programs (EAP), has appointed Derek Newell as its new Chief Executive Officer. This transition follows an investment by Lightyear Capital, a New York-based private equity firm, which signifies a commitment to fueling CuraLinc's growth. Derek Newell comes with a robust 25-year background in various healthcare domains, making him a pivotal appointment for the company. His leadership is poised to elevate CuraLinc's reach and enhance its innovative offerings. Sean Fogarty, the founder of CuraLinc, will transition to an Executive Chairman position, continuing his support in advancing the company's mission. CuraLinc boasts an impressive client base of over 4,600 globally, signifying its success in revolutionizing workforce mental health since 2008. The company remains steadfast in leveraging connectivity and personalized advocacy to enhance employee wellbeing.

Sectors

  • Healthcare
  • Private Equity
  • Technology

Geography

  • United States – CuraLinc Healthcare is based in Chicago, Illinois, and Lightyear Capital operates out of New York, both indicating their U.S. geographical relevance.

Industry

  • Healthcare – The article discusses CuraLinc Healthcare, which operates in the mental health care sector, providing services to improve employee wellbeing.
  • Private Equity – The article involves Lightyear Capital, a private equity firm, which invested in CuraLinc, indicating its influence in shaping the company's strategic direction.
  • Technology – CuraLinc combines mental health care with technology to enhance connectivity and personalized advocacy, marking its relevance in the technology sector.

Financials

  • $6.5 billion – Assets under management by Lightyear Capital, as of September 30, 2024.

Participants

NameRoleTypeDescription
CuraLinc HealthcareTarget CompanyCompanyA healthcare provider focusing on mental health and employee assistance programs.
Lightyear CapitalInvesting FirmCompanyA private equity firm that invested in CuraLinc, bolstering its growth potential.
Derek NewellNew CEOPersonAppointed as CEO of CuraLinc, bringing over 25 years of healthcare experience.
Sean FogartyExecutive ChairmanPersonFounder of CuraLinc, transitioning to Executive Chairman to continue supporting the company's mission.